跳至主要内容
临床试验/NCT01275885
NCT01275885已完成4 期

Vitamin D Intervention in Infants - Pilot

Helsinki University Central Hospital1 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2010年8月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
113
试验地点
1
主要终点
S-25OHD concentration after vitamin D supplementation to infants

研究概览

简要总结

The aims of the present study are to evaluate the concentrations of vitamin D in the plasma and of calcium in the plasma and in the urine as well as to evaluate bone mineral density using peripheral quantitative computed tomography (pQCT), after supplementation of vitamin D with 30µg (1200 IU) and 40µg (1600 IU), in comparison with currently recommended supplementation of vitamin D with 10µg (400 IU). In this pilot study supplementation is given to infants from 2 weeks of age to 3 months of age.

详细描述

Vitamin D deficiency is common around the world. In Finland vitamin D levels are low in all age groups. Especially infants are predisposed to vitamin D deficiency. Partly this is due to low exposure to sunlight but mainly it is due to low dietary intake of vitamin D. Vitamin D prophylaxis was introduced in Finland in the 1950´s to overcome rickets. However, the recommended dose has decreased from 50µg (2000 IU) in the 1960´s to 10µg (400 IU) from beginning of the 1990´s. The serum concentration of 25-hydroxyvitamin D (S-25OHD) is used as a marker of vitamin D status in the body. Although there is no consensus of optimal concentration of S-25OHD, it has been proposed that concentrations lower than 50 nmol/l indicate deficiency. According to recent findings on 25-OHD concentrations in Finnish children, currently recommended intake of vitamin D is inadequate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者
是

入选标准

  • •healthy Caucasian women with an uneventful pregnancy
  • •healthy infants born at term and appropriate for gestational age

排除标准

  • 未提供

研究组 & 干预措施

Vitamin D3 40µg

Active Comparator

干预措施: cholecalciferol (D3) (Dietary Supplement)

Vitamin D3 10µg

Active Comparator

干预措施: cholecalciferol (D3) (Dietary Supplement)

Vitamin D3 30µg

Active Comparator

干预措施: cholecalciferol (D3) (Dietary Supplement)

结局指标

主要结局

S-25OHD concentration after vitamin D supplementation to infants

时间窗: after 10 weeks of supplementation

The primary endpoint is the concentration of 25OHD in serum after daily supplementation with vitamin D (10µg / 30µg / 40µg orally). Vitamin D supplementation is given to infants from 2 weeks of age to 3 months of age.

次要结局

  • concentration of calcium in the plasma and in the urine(after 10 weeks of supplementation)
  • bone mineral density(after 10 weeks of supplementation)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Vitamin D Intervention in Infants - Pilot | 临床试验